Skip to main content
$0.82 -$0.04 (-4.9%)

12:01 PM EST on 03/04/24

Clover Health (NASDAQ:CLOV)

CAPS Rating: 4 out of 5

Current Price $0.82 Mkt Cap $421.9M
Open $0.87 P/E Ratio -1.83
Prev. Close $0.87 Div. (Yield) $0.00 (0.0%)
Daily Range $0.82 - $0.88 Volume 6,556,153
52-Wk Range $0.71 - $1.63 Avg. Daily Vol. 7,758,964


How do you think NASDAQ:CLOV will perform against the market?

Add Stock to CAPS Watchlist

All Players

81 Outperform
4 Underperform

All-Star Players

3 Outperform
0 Underperform

Wall Street

0 Outperform
0 Underperform

Top NASDAQ:CLOV Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

jisifu (< 20)
Submitted February 22, 2022

I started writing a few articles on hc and tech changes., clover has a huge TAM and a differentiable product and business model that has a durable sustainable advantage to their larger competition. The… More

link8822 (70.76)
Submitted June 10, 2021

Stock squeeze will run out of steam and crash


Fools bullish on NASDAQ:CLOV are also bullish on:

Fools bearish on NASDAQ:CLOV are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about CLOV.


Member Avatar jisifu (< 20) Submitted: 2/22/2022 1:24:15 AM : Outperform Start Price: $9.77 NASDAQ:CLOV Score: -125.46

I started writing a few articles on hc and tech changes.

basically, clover has a huge TAM and a differentiable product and business model that has a durable sustainable advantage to their larger competition. The clover assistant is a software that presents useful information to the doctor about a patient and it's a bigger deal that one thinks when it comes to detecting diseases and making sure screening is regular.

it's really an interesting approach where an insurer is taking a proactive approach in preventive precision medicine.

Biggest difference from last year and this year is that they have 20+ patents now to solidify their technological moat. the patents give clover an opportunity to pave way to a new wave of adoption for info tech organizing capabilities by physicians.

lives that are managed by their software are +20% in gross margin over their counterparts who dont use the software. this is promising since the industry is known for relatively low margins between 10-15% with debt burden.


Member Avatar Margaritarius (< 20) Submitted: 1/23/2022 12:06:24 AM : Outperform Start Price: $2.37 NASDAQ:CLOV Score: -83.37

Speculative Pick (2% max allocation would be wise), Health Care Sector: Many companies who went public via SPACs have been gutted as those who rushed in, now rush out just as quickly, but many fail to realize that SPACs raised debt-free cash for these companies to accelerate their expansion into positive cash flows or outright profit margin; Clover is one such company; With a total debt to capital ratio of 4.61%, reported last Sept, she's operating at 1/10th the average debt ratio in her industry; Pretty smart move ahead of climbing interest rates if you ask me; CLOV also grew revenue 89% in the 3rd quarter as she expands her AI-enabled Medicare Advantage services into new states steadily stealing market share from the broader industry; Palihapatiya’s pick uses AI to bring providers and patients together; Providers actually recommend plans to patients so that they can get the care they need; Brilliant! It’s also recession proof; I’m likely to pass on a new EV when things get tight, but I’m pretty sure I’ll spring for coverage to get the health care I need to stay alive


Member Avatar link8822 (70.76) Submitted: 6/10/2021 1:32:01 AM : Underperform Start Price: $18.09 NASDAQ:CLOV Score: +116.58

Stock squeeze will run out of steam and crash


Find the members with the highest scoring picks in CLOV.

Score Leader


TMFBwithbike (51.56) Score: +267.54

The Score Leader is the player with the highest score across all their picks in CLOV.

Member Name Member
Call Time
Score Commentary
TMFjimhalley < 20 3/12/2021 Underperform 1Y $8.80 -90.52% +30.28% +120.80 1 Comment
link8822 70.76 6/10/2021 Underperform 1Y $18.09 -95.39% +21.19% +116.58 1 Comment
TMFdjagielski 20.47 6/14/2021 Underperform 5Y $14.65 -94.30% +20.77% +115.08 0 Comment
baf72167 < 20 6/21/2021 Underperform 5Y $11.40 -92.68% +22.09% +114.77 0 Comment
kkconway 84.23 8/9/2023 Outperform 5Y $1.54 -45.82% +14.16% -59.98 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. Margaritarius < 20 1/24/2022 Outperform 5Y $2.37 -64.72% +18.65% -83.37 1 Comment
MexicanFool99 64.01 1/7/2022 Outperform 5Y $3.31 -74.79% +9.54% -84.33 0 Comment
angelawirya < 20 1/5/2022 Outperform 5Y $3.86 -78.38% +7.43% -85.81 0 Comment
cjohn703 < 20 3/31/2022 Outperform 5Y $3.53 -76.36% +12.12% -88.48 0 Comment
Playa17 < 20 10/5/2022 Outperform 5Y $1.83 -54.40% +37.28% -91.69 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CLOV.